DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20204054

Maple syrup urine disease presenting as severe neonatal metabolic encephalopathy: a case report

Giridhar S., Umadevi L., Rathinasamy M., Antony J.

Abstract


We report a 17 day old boy, who developed progressive encephalopathy, after an apparent period of normalcy. Magnetic resonance imaging showed diffusion restriction in myelinated areas like, a pattern suggestive of maple syrup urine disease. Dried blood spots for tandem mass spectrometry and urine for gas chromatography mass spectrometry confirmed elevation and excretion of branched chain amino acids respectively.  After peritoneal dialysis, baby improved but continued to have residual neurological deficit, in spite of MSUD-specialized diet. Molecular studies confirmed the diagnosis. This report highlights the need for early identification of these infants to optimize neurological outcomes.


Keywords


Inborn error of metabolism, Maple syrup urine disease, Neonatal metabolic encephalopathy

Full Text:

PDF

References


Blackburn PR, Gass JM, Vairo FPE, Farnham KM, Atwal HK, Macklin S, et al. Maple syrup urine disease: mechanisms and management. The application of clinical genetics. 2017;10:57-66.

Nagaraja D, Mamatha SN, De T, Christopher R. Screening for inborn errors of metabolism using automated electrospray tandem mass spectrometry: Study in high-risk Indian population. Clinical Biochemistry. 2010;43(6):581-8.

Axler O, Holmquist P. Intermittent Maple Syrup Urine Disease: Two Case Reports. Pediatrics 2014;133:e458-60.

Yang N. Analysis of clinical manifestations and results of mass spectrometry in diabetic patients. Chinese Medical Journal. 2012;92(40):2839-42.

Muller K, Kahn T, Wendel U. Is demyelination a feature of maple syrup urine disease?. Pediatr Neurol. 1993;9:375-82.

Chung DT, Shin VE. Maple syrup urine disease (branched chain ketoaciduria) In: Scriver CR, Beaudet AL, editors. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2001:1971-2005.

Strauss KA, Puffenberger EG, Carson VJ. Maple Syrup Urine Disease. Gene reviews, 2006. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1319/. Accessed on 20 April 2020.

Brismar J, Aqeel A, Brismar G, Coates R, Gascon G, Ozand P. Maple syrup urine disease: findings on CT and MR scans of the brain in 10 infants. Am J Neuroradiol. 1990;11:1219-28.

Sakai M, Inoue Y, Oba H, Ishiguro A, Sekiguchi K, Tsukune Y, et al. Age dependence of diffusion-weighted magnetic resonance imaging findings in maple syrup urine disease encephalopathy. J Comput Assist Tomogr. 2005;29:524-7.

Morton DH, Strauss KA, Robinson DL, Puffenberger EG, Kelley RI. Diagnosis and treatment of maple syrup disease: A study of 36 patients. Pediatrics. 2002;109: 999-1008.

Stepien KM, Wilcox G, Green D, Fletcher S, Hendriksz CJ. The management of a case with maple syrup urine disease with haemofiltration and nutritional support in the perioperative period. Journal of Rare Disorders, Diagnosis & Therapy. 2015;1:2.

Fekete G, Plattner R., Crabb DW, Zhang B, Harris R.A, Heerema N, et al. Localization of the human gene for the El-alpha subunit of branched chain keto acid dehydrogenase (BCKDHA) to chromosome 19q13.1-q13.2. Cytogenet. Cell Genet. 1989;50: 236-7.

Sharma S, Kumar P, Agarwal R, Kabra M, Deorari A, Paul V. Approach to inborn errors of metabolism presenting in the neonate. The Indian Journal of Pediatrics. 2008;75(3):271-6.